Newracle Genetics - Crunchbase Company Profile & Funding

Q: Who invested in Newracle Genetics?

Newracle Genetics has 19 investors including Korea Development Bank And Alborism.

Q: When was the last funding round for Newracle Genetics?

Newracle Genetics closed its last funding round on obfuscated from a Series C round.

Q: How much funding has Newracle Genetics raised to date?

Newracle Genetics has raised obfuscated.

Overview

Newracle Genetics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Newracle Genetics

CB Rank

74782

Newracle Genetics is a bio venture company that develops gene therapy products for neurological diseases.

Founded

obfuscation

Private

Series C

Seoul, Seoul-t'ukpyolsi, South Korea

11-50

neuraclegen.com

Biotechnology

Medical

Pharmaceutical

Funding Rounds

Series C

OBF

obfuscation

Series C

OBF

obfuscation

Series B

OBF

obfuscation

Details

Legal Name

Newracle Genetics Co., Ltd.

Also Known As

(주)뉴라클제네틱스, Neuracle Genetics

Operating Status

Active

Company Type

For Profit

About the Company

Newracle Genetics is a clinical-stage biotechnology company that uses AAV gene therapy to treat neurodegenerative disorders and other intractable and rare diseases, helping patients reduce their suffering.

Phone Number

+82 02 6951 5024

Contact Email

info@neuraclegen.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Runway Speculation

Products & Services

NG101

A gene therapy candidate for wet Age-related Macular Degeneration (wAMD) using AAV vector technology to deliver therapeutic genes to treat abnormal blood vessel growth in the retina.

NG201-NP (Neuropathic Pain Gene Therapy)

A gene therapy candidate targeting chronic neuropathic pain by delivering therapeutic genes via AAV vectors to modulate nerve function and alleviate pain symptoms.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series C - Newracle Genetics	2	obfuscated obfuscation	—	Series C
obfuscated obfuscation	Series C - Newracle Genetics	2	obfuscated obfuscation	—	Series C
obfuscated obfuscation	Series C - Newracle Genetics	2	obfuscated obfuscation	—	Series C
obfuscated obfuscation	Series C - Newracle Genetics	2	obfuscated obfuscation	—	Series C
obfuscated obfuscation	Series C - Newracle Genetics	2	obfuscated obfuscation	—	Series C

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series C - Newracle Genetics	2	obfuscated obfuscation	—	Series C
obfuscated obfuscation	Series C - Newracle Genetics	2	obfuscated obfuscation	—	Series C
obfuscated obfuscation	Series C - Newracle Genetics	2	obfuscated obfuscation	—	Series C
obfuscated obfuscation	Series C - Newracle Genetics	2	obfuscated obfuscation	—	Series C
obfuscated obfuscation	Series C - Newracle Genetics	2	obfuscated obfuscation	—	Series C

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Korea Development Bank	—	Series C - Newracle Genetics	—
Korea Development Bank	—	Series C - Newracle Genetics	—
Korea Development Bank	—	Series C - Newracle Genetics	—
Korea Development Bank	—	Series C - Newracle Genetics	—
Korea Development Bank	—	Series C - Newracle Genetics	—